Clinical trial
A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating…
NCT00152256 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00152256 |
|---|---|
| Title | A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids |
| Official title | A Phase 3,6-Month, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Two Doses of Asoprisnil Versus Placebo in Subjects With Uterine Leiomyomata |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fibroid Uterus, Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Fibroids |
| Intervention type | Drug |
| Interventions | Asoprisnil, Placebo |
| Enrollment | 239 |
| Start date | Sep 1, 2003 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Sep 9, 2005 |
| Last update posted | May 29, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: